CEL 9.03 Cellcom Israel $CEL Hit a 52 week low of 9.02

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 11:03 AM

CEL 9.03 Cellcom Israel $CEL Hit a 52 week low of 9.02 Closing the day 10:42 at 9.03 -0.18 -1.95% With a day low of 9.02 and a total volume of 15,015.

CEL Recent Posts: http://investorshangout.com/Cellcom-Israel-CEL-50483/

CEL Cellcom Israel Recent Headline News

25.8% Return Seen to Date on SmarTrend Cellcom Israel Call (CEL)
Comtex SmarTrend(R) - Thu Nov 13, 9:22AM CST
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 6 months, Cellcom Israel has returned 25.78% as of today's recent price of $9.33.
CEL: 9.02 (-0.19)

Cellcom Israel ltd. Announces Annual General Meeting of Shareholders
PR Newswire - Thu Nov 13, 5:21AM CST
Cellcom Israel Ltd. (NYSE: CEL) announced today that an Annual General Meeting of Shareholders (the "Meeting"

of Cellcom Israel Ltd. (the "Company"

will be held on Tuesday, December 23, 2014, at 4:00 p.m. (Israel time), at the offices of the Company, 10 Hagavish Street, Netanya, Israel. The record date for the Meeting is Monday, November 24, 2014.
CEL: 9.02 (-0.19)

Cellcom Israel's (CEL) CEO Nir Sztern on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 9:36AM CST

CEL: 9.02 (-0.19)

Cellcom Israel EPS of $0.28
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 6:04AM CST

CEL: 9.02 (-0.19)

Cellcom posts 3Q profit
Automated Insights - Wed Nov 12, 4:04AM CST
NETANYA, Israel (AP) _ Cellcom Israel Ltd. (CEL) on Wednesday reported profit of $29 million in its third quarter.
CEL: 9.02 (-0.19)

Cellcom Israel Announces Third Quarter 2014 Results
PR Newswire - Wed Nov 12, 1:06AM CST
THIRD QUARTER 2014 HIGHLIGHTS (compared to third quarter of 2013):
CEL: 9.02 (-0.19)

Cellcom Israel Has Returned 21.5% Since SmarTrend Recommendation (CEL)
Comtex SmarTrend(R) - Wed Nov 05, 4:59PM CST
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 6 months, Cellcom Israel has returned 21.48% as of today's recent price of $9.87.
CEL: 9.02 (-0.19)

Cellcom Israel Shares Down 16.1% Since SmarTrend's Sell Call (CEL)
Comtex SmarTrend(R) - Wed Oct 29, 11:04AM CDT
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 6 months, Cellcom Israel has returned 16.15% as of today's recent price of $10.54.
CEL: 9.02 (-0.19)

Cellcom Israel Schedules Third Quarter 2014 Results Release For November 12, 2014
PR Newswire - Sun Oct 26, 7:56AM CDT
Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company"

, announced today that it will be releasing its financial results for the third quarter ended September 30, 2014 on Wednesday, November 12, 2014, before the US markets open.
CEL: 9.02 (-0.19)

Downtrend Call Working As Cellcom Israel Stock Falls 14.6% (CEL)
Comtex SmarTrend(R) - Wed Oct 15, 9:27AM CDT
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 5 months, Cellcom Israel has returned 14.56% as of today's recent price of $10.74.
CEL: 9.02 (-0.19)

Nokia Enhances Offerings, Cuts Vital Deals: Should You Buy? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 1:00PM CDT
On Oct 8, 2014, Zacks Investment Research upgraded Finnish telecommunication company Nokia Corporation (NOK) by a notch to a Zacks Rank #2 (Buy).
CEL: 9.02 (-0.19), BBRY: 10.94 (-0.26), ARUN: 21.44 (-0.13), NOK: 7.67 (-0.19)

Is Cellcom Israel (CEL) Stock A Great Combo of Value and Growth? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 7:46AM CDT
Cellcom Israel may be an interesting play thanks to its forward PE of 10.5, its P/S ratio of 0.82, and its decent dividend yield of 2.15%
CEL: 9.02 (-0.19)

UPRO, NJ, CEL, SYT, HUN, CALD Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 03, 4:23AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares UltraPro S&P 500 (NYSE:UPRO), Nidec Corp (NYSE:NJ), Columbus Energy Ltd (NYSE:CEL), Syngenta AG (NYSE:SYT), Huntsman Corp (NYSE:HUN), Callidus Software Inc (NASDAQ:CALD) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CEL: 9.02 (-0.19), UPRO: 128.60 (-0.60), SYT: 64.97 (+0.06), NJ: 15.88 (-0.17), CALD: 15.84 (-0.22), HUN: 25.75 (+0.01)

Cellcom Israel Down 10.3% Since SmarTrend Downtrend Call (CEL)
Comtex SmarTrend(R) - Fri Sep 26, 9:58AM CDT
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 5 months, Cellcom Israel has returned 10.34% as of today's recent price of $11.27.
CEL: 9.02 (-0.19)

Cellcom Israel reports dismissal of purported class action and filing of a purported class action
M2 - Wed Sep 24, 6:51AM CDT
Israeli cellular provider Cellcom Israel Ltd (NYSE:CEL) (TASE:CEL.TA) announced on Tuesday the dismissal with prejudice by the Israeli Supreme Court an appeal filed in 2011 against the dismissal with prejudice of a purported class action filed against Netvision Ltd, the company's wholly owned subsidiary, and other defendants, regarding on-line auctions of goods.
CEL: 9.02 (-0.19)

Cellcom Israel claims win in court case
M2 - Wed Sep 24, 4:58AM CDT
Israel-based Cellcom Israel Ltd (NYSE: CEL) (TASE: CEL) said that the Israeli Supreme Court dismissed with prejudice an appeal filed in 2011 against the dismissal with prejudice of a purported class action filed against the company's Netvision Ltd subsidiary and other defendants regarding on-line auctions of goods.
CEL: 9.02 (-0.19)

Cellcom Israel Ltd. Announces Dismissal of Purported Class Action and Filing of a Purported Class Action
PR Newswire - Tue Sep 23, 6:39AM CDT
Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company"

announced today that the Israeli Supreme Court dismissed with prejudice an appeal filed in 2011 against the dismissal with prejudice of a purported class action filed against Netvision Ltd., the Company's wholly owned subsidiary, and other defendants, regarding on-line auctions of goods. The total amounts claimed from the defendents, had the lawsuit been certified as class action wasn't quantified by the plaintiffs. In addition, a purported class action was filed against 013 Netvision Ltd., or Netvision, the Company's wholly owned subsidiary, in relation to sums Netvision allegedly wrongfully charged its subscribers, relating to their payment method. The total amounts claimed from Netvision, if the lawsuit is certified as class action is estimated by the plaintiff to be over NIS 50 million (and under certain mistaken assumptions detailed elsewhere in the lawsuit- over NIS 1 billion). At this early stage the Company cannot assess the lawsuit's chances of success.
CEL: 9.02 (-0.19)

Cellcom Israel announces board changes under Israeli law
M2 - Tue Sep 23, 6:34AM CDT
Israeli cellular provider Cellcom Israel Ltd (NYSE:CEL) (TASE:CEL.TA) announced on Monday the resignation of Rafi Bisker, Haim Gavrieli and Edith Lusky resigned from their office as members of the company's board of directors, effective 21 September 2014.
CEL: 9.02 (-0.19)

Cellcom Israel enters into agreements with Golan and Pelephone for networks
M2 - Tue Sep 23, 6:29AM CDT
Israeli cellular provider Cellcom Israel Ltd (NYSE:CEL) (TASE:CEL.TA) announced on Monday, that following the network sharing agreements, and the Israeli Ministry of Communications requirements regarding network sharing, it has now signed more agreements.
CEL: 9.02 (-0.19)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....